1 |
Oudah KH, Mahmoud WR, Awadallah FM, Taher AT, Abbas SE, Allam HA, Vullo D, Supuran CT. Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2023;38:12-23. [DOI: 10.1080/14756366.2022.2132485] [Reference Citation Analysis]
|
2 |
Ejam SS, Saleh RO, Catalan Opulencia MJ, Najm MA, Makhmudova A, Jalil AT, Abdelbasset WK, Al-Gazally ME, Hammid AT, Mustafa YF, Sergeevna SE, Karampoor S, Mirzaei R. Pathogenic role of 25-hydroxycholesterol in cancer development and progression. Future Oncol 2022;18:4415-42. [PMID: 36651359 DOI: 10.2217/fon-2022-0819] [Reference Citation Analysis]
|
3 |
Képes Z, Barkóczi A, Szabó JP, Kálmán-Szabó I, Arató V, Garai I, Árkosy P, Jószai I, Deák Á, Kertész I, Hajdu I, Trencsényi G. In Vivo Assessments of Mesoblastic Nephroma (Ne/De) and Myelomonoblastic Leukaemia (My1/De) Tumour Development in Hypercholesterolemia Rat Models. Int J Mol Sci 2022;23. [PMID: 36361850 DOI: 10.3390/ijms232113060] [Reference Citation Analysis]
|
4 |
Rudiansyah M, Abdalkareem Jasim S, S Azizov B, Samusenkov V, Kamal Abdelbasset W, Yasin G, Mohammad HJ, Jawad MA, Mahmudiono T, Hosseini-Fard SR, Mirzaei R, Karampoor S. The emerging microbiome-based approaches to IBD therapy: From SCFAs to urolithin A. J Dig Dis 2022;23:412-34. [PMID: 36178158 DOI: 10.1111/1751-2980.13131] [Reference Citation Analysis]
|